Creating a quick test to detect asthma-triggering allergies
Official title: Development of a highly sensitive and specific POCT testing asthma triggering allergic IgE
Funded at Allerdia INC · NIH-10922887 · Data updated 2026-11-12
This study is working on a new, easy-to-use test that helps asthma patients quickly find out their allergy levels to common environmental triggers, especially focusing on helping those in minority groups who face more challenges with asthma.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Allerdia INC NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | February 1, 2023 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $1,109,675 |
| NIH project number | 2R44HL167289-02 |
| Project ID | NIH-10922887 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals from minority groups, particularly Black, Hispanic, American Indian, Native Alaskan, and Asian populations, who suffer from allergic asthma.
✕Less likely to help
Patients who do not have allergic asthma or those who are not part of the targeted minority groups may not benefit from this research.
What this research studies
This research aims to develop a new Point-Of-Care Test that can quickly and accurately identify allergic IgE levels related to environmental allergens in asthma patients. The test is designed to be convenient and cost-effective, addressing the significant health disparities faced by minority groups who are disproportionately affected by asthma. By improving the accuracy of allergy detection, the research seeks to enhance patient care and promote healthier living. The methodology involves innovative testing techniques that aim to reduce false positives commonly seen in current IgE tests.
Why it matters
Potential benefit: If successful, this research could provide patients with a reliable and rapid method to identify asthma triggers, leading to better management of their condition.
How similar studies have gone: While the approach of developing a rapid point-of-care test for allergic IgE detection is innovative, similar methodologies have shown promise in other areas of allergy testing.
Where this research is happening
-
Allerdia INC
Los Angeles, United States Active
Researchers
- Principal investigator: Zhang, Ke — Allerdia INC
- Study coordinator: Zhang, Ke
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.